Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance and show enhanced efficacy in vivo

The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications

(2011) Klaus Podar et al.   BRITISH JOURNAL OF HAEMATOLOGY

Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma

(2011) Masahiro Abe   INTERNATIONAL JOURNAL OF HEMATOLOGY

Future Directions of Next-Generation Novel Therapies, Combination Approaches, and the Development of Personalized Medicine in Myeloma

(2011) Constantine S. Mitsiades et al.   JOURNAL OF CLINICAL ONCOLOGY

Establishing a new rat model of central venous sinus thrombosis and analyzing its pathophysiological and apoptotic changes

(2011) Hui Yang et al.   JOURNAL OF NEUROSCIENCE METHODS

Overcoming in vivo barriers to targeted nanodelivery

(2011) Adrian Chrastina et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Multifunctionality of lipid-core micelles for drug delivery and tumour targeting

(2010) Rupa R. Sawant et al.   MOLECULAR MEMBRANE BIOLOGY

Advances in polymeric micelles for drug delivery and tumor targeting

(2010) Uttam Kedar et al.   Nanomedicine-Nanotechnology Biology and Medicine

Mixed pH-Sensitive Polymeric Micelles for Combination Drug Delivery

(2010) Younsoo Bae et al.   PHARMACEUTICAL RESEARCH

Fullerenol−Cytotoxic Conjugates for Cancer Chemotherapy

(2009) Padmaparna Chaudhuri et al.   ACS Nano

Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment

(2008) Z. Liu et al.   CANCER RESEARCH

ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology

(2008) R. Schmidmaier et al.   CURRENT MEDICINAL CHEMISTRY

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

(2008) H. Maeda et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Multifunctional Micellar Nanomedicine for Cancer Therapy

(2008) Elvin Blanco et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Selectively Targeting T- and B-Cell Lymphomas: A Benzothiazole Antagonist of α4β1Integrin

(2008) Richard D. Carpenter et al.   JOURNAL OF MEDICINAL CHEMISTRY

Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma

(2008) K Hatano et al.   ONCOGENE